PATENT CLAIM ANALYSIS

Application Number: 15885620
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "458000"]

Abstract:
Provided herein are cannabinoid-containing complex mixtures suitable for use as active pharmaceutical ingredients. The complex mixtures are comprised of the major cannabinoid, cannabidiol, a first minor cannabinoid, which is cannabigerol, at least a first selected terpene, and optionally a second minor cannabinoid. Also provided are methods of making the complex mixtures, pharmaceutical compositions comprising the complex mixture, and methods of using the pharmaceutical compositions for the treatment of mast cell-related immune disorders, including allergy and atopy (allergic asthma, eczema, rhinitis), mast cell activation syndrome (MCAS), physical and chemical urticarias, idiopathic urticaria, Crohn's disease, inflammatory bowel disorder, dermatitis and contact dermatitis, arthritis and rheumatoid arthritis, canine mastocytosis, and allergy and inflammation in cattle, swine, etc. The methods of the present invention further relate to the treatment of various basophil-mediated immune disorders.

Claim (Index 12):
The active ingredient of  claim 9 , wherein the first and the second selected terpene are limonene and linalool.

Metadata:
- Claim Count in Document: 90.0
- Percentile: 86.0
- Lexical Diversity: 1.77778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15729565', '15554209', '15152253', '15676407', '10243059']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7686290177840163
- 35 USC 102 Novelty (BERT): 0.5905925926123546
- Combined Prediction Score: 0.7508253752668501
- Mean Citation Score: 381.115562
- Max Citation Score: 523.5104
- Similarity Product: 399.5171992073059

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test